Global Gout Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 80994
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Gout Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gout Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gout Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Gout Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

NSAIDs

Corticosteroids

Colchicine

Urate-Lowering Agents

Market segment by Application, can be divided into

Acute Gout

Chronic Gout

Market segment by players, this report covers

Takeda Pharmaceutical Company

Novartis

AstraZeneca

GlaxoSmithKline

Merck

Regeneron Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Gout Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Gout Therapeutics, with revenue, gross margin and global market share of Gout Therapeutics from 2019 to 2021.

Chapter 3, the Gout Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gout Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Gout Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gout Therapeutics

1.2 Classification of Gout Therapeutics by Type

1.2.1 Overview: Global Gout Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gout Therapeutics Revenue Market Share by Type in 2020

1.2.3 NSAIDs

1.2.4 Corticosteroids

1.2.5 Colchicine

1.2.6 Urate-Lowering Agents

1.3 Global Gout Therapeutics Market by Application

1.3.1 Overview: Global Gout Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Acute Gout

1.3.3 Chronic Gout

1.4 Global Gout Therapeutics Market Size & Forecast

1.5 Global Gout Therapeutics Market Size and Forecast by Region

1.5.1 Global Gout Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gout Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Gout Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Gout Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Gout Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Gout Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Gout Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gout Therapeutics Market Drivers

1.6.2 Gout Therapeutics Market Restraints

1.6.3 Gout Therapeutics Trends Analysis

2 Company Profiles

2.1 Takeda Pharmaceutical Company

2.1.1 Takeda Pharmaceutical Company Details

2.1.2 Takeda Pharmaceutical Company Major Business

2.1.3 Takeda Pharmaceutical Company Gout Therapeutics Product and Solutions

2.1.4 Takeda Pharmaceutical Company Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Takeda Pharmaceutical Company Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Gout Therapeutics Product and Solutions

2.2.4 Novartis Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 AstraZeneca

2.3.1 AstraZeneca Details

2.3.2 AstraZeneca Major Business

2.3.3 AstraZeneca Gout Therapeutics Product and Solutions

2.3.4 AstraZeneca Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 AstraZeneca Recent Developments and Future Plans

2.4 GlaxoSmithKline

2.4.1 GlaxoSmithKline Details

2.4.2 GlaxoSmithKline Major Business

2.4.3 GlaxoSmithKline Gout Therapeutics Product and Solutions

2.4.4 GlaxoSmithKline Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 GlaxoSmithKline Recent Developments and Future Plans

2.5 Merck

2.5.1 Merck Details

2.5.2 Merck Major Business

2.5.3 Merck Gout Therapeutics Product and Solutions

2.5.4 Merck Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Merck Recent Developments and Future Plans

2.6 Regeneron Pharmaceuticals

2.6.1 Regeneron Pharmaceuticals Details

2.6.2 Regeneron Pharmaceuticals Major Business

2.6.3 Regeneron Pharmaceuticals Gout Therapeutics Product and Solutions

2.6.4 Regeneron Pharmaceuticals Gout Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Regeneron Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gout Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Gout Therapeutics Players Market Share

3.2.2 Top 10 Gout Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Gout Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gout Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Gout Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gout Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Gout Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Gout Therapeutics Revenue by Type (2016-2026)

6.2 North America Gout Therapeutics Revenue by Application (2016-2026)

6.3 North America Gout Therapeutics Market Size by Country

6.3.1 North America Gout Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Gout Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Gout Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Gout Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Gout Therapeutics Revenue by Type (2016-2026)

7.2 Europe Gout Therapeutics Revenue by Application (2016-2026)

7.3 Europe Gout Therapeutics Market Size by Country

7.3.1 Europe Gout Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Gout Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Gout Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Gout Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Gout Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Gout Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Gout Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Gout Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Gout Therapeutics Market Size by Region

8.3.1 Asia-Pacific Gout Therapeutics Revenue by Region (2016-2026)

8.3.2 China Gout Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Gout Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Gout Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Gout Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Gout Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Gout Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Gout Therapeutics Revenue by Type (2016-2026)

9.2 South America Gout Therapeutics Revenue by Application (2016-2026)

9.3 South America Gout Therapeutics Market Size by Country

9.3.1 South America Gout Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Gout Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Gout Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Gout Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Gout Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Gout Therapeutics Market Size by Country

10.3.1 Middle East & Africa Gout Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Gout Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Gout Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Gout Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gout Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gout Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gout Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gout Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gout Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. Takeda Pharmaceutical Company Corporate Information, Head Office, and Major Competitors

Table 7. Takeda Pharmaceutical Company Major Business

Table 8. Takeda Pharmaceutical Company Gout Therapeutics Product and Solutions

Table 9. Takeda Pharmaceutical Company Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Gout Therapeutics Product and Solutions

Table 13. Novartis Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 15. AstraZeneca Major Business

Table 16. AstraZeneca Gout Therapeutics Product and Solutions

Table 17. AstraZeneca Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline Major Business

Table 20. GlaxoSmithKline Gout Therapeutics Product and Solutions

Table 21. GlaxoSmithKline Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Merck Corporate Information, Head Office, and Major Competitors

Table 23. Merck Major Business

Table 24. Merck Gout Therapeutics Product and Solutions

Table 25. Merck Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 27. Regeneron Pharmaceuticals Major Business

Table 28. Regeneron Pharmaceuticals Gout Therapeutics Product and Solutions

Table 29. Regeneron Pharmaceuticals Gout Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Global Gout Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 31. Global Gout Therapeutics Revenue Share by Players (2019-2021)

Table 32. Breakdown of Gout Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Gout Therapeutics Players Head Office, Products and Services Provided

Table 34. Gout Therapeutics Mergers & Acquisitions in the Past Five Years

Table 35. Gout Therapeutics New Entrants and Expansion Plans

Table 36. Global Gout Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 37. Global Gout Therapeutics Revenue Share by Type (2016-2021)

Table 38. Global Gout Therapeutics Revenue Forecast by Type (2021-2026)

Table 39. Global Gout Therapeutics Revenue by Application (2016-2021)

Table 40. Global Gout Therapeutics Revenue Forecast by Application (2021-2026)

Table 41. North America Gout Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 42. North America Gout Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 43. North America Gout Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 44. North America Gout Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 45. North America Gout Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 46. North America Gout Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 47. Europe Gout Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 48. Europe Gout Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 49. Europe Gout Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 50. Europe Gout Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 51. Europe Gout Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 52. Europe Gout Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 53. Asia-Pacific Gout Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 54. Asia-Pacific Gout Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 55. Asia-Pacific Gout Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 56. Asia-Pacific Gout Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 57. Asia-Pacific Gout Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 58. Asia-Pacific Gout Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 59. South America Gout Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 60. South America Gout Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 61. South America Gout Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 62. South America Gout Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 63. South America Gout Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 64. South America Gout Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 65. Middle East & Africa Gout Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 66. Middle East & Africa Gout Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 67. Middle East & Africa Gout Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 68. Middle East & Africa Gout Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 69. Middle East & Africa Gout Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 70. Middle East & Africa Gout Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Gout Therapeutics Picture

Figure 2. Global Gout Therapeutics Revenue Market Share by Type in 2020

Figure 3. NSAIDs

Figure 4. Corticosteroids

Figure 5. Colchicine

Figure 6. Urate-Lowering Agents

Figure 7. Gout Therapeutics Revenue Market Share by Application in 2020

Figure 8. Acute Gout Picture

Figure 9. Chronic Gout Picture

Figure 10. Global Gout Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Gout Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Gout Therapeutics Revenue Market Share by Region (2016-2026)

Figure 13. Global Gout Therapeutics Revenue Market Share by Region in 2020

Figure 14. North America Gout Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Gout Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Gout Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Gout Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Gout Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Gout Therapeutics Market Drivers

Figure 20. Gout Therapeutics Market Restraints

Figure 21. Gout Therapeutics Market Trends

Figure 22. Takeda Pharmaceutical Company Recent Developments and Future Plans

Figure 23. Novartis Recent Developments and Future Plans

Figure 24. AstraZeneca Recent Developments and Future Plans

Figure 25. GlaxoSmithKline Recent Developments and Future Plans

Figure 26. Merck Recent Developments and Future Plans

Figure 27. Regeneron Pharmaceuticals Recent Developments and Future Plans

Figure 28. Global Gout Therapeutics Revenue Share by Players in 2020

Figure 29. Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 30. Global Top 3 Players Gout Therapeutics Revenue Market Share in 2020

Figure 31. Global Top 10 Players Gout Therapeutics Revenue Market Share in 2020

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 33. Global Gout Therapeutics Revenue Share by Type in 2020

Figure 34. Global Gout Therapeutics Market Share Forecast by Type (2021-2026)

Figure 35. Global Gout Therapeutics Revenue Share by Application in 2020

Figure 36. Global Gout Therapeutics Market Share Forecast by Application (2021-2026)

Figure 37. North America Gout Therapeutics Sales Market Share by Type (2016-2026)

Figure 38. North America Gout Therapeutics Sales Market Share by Application (2016-2026)

Figure 39. North America Gout Therapeutics Revenue Market Share by Country (2016-2026)

Figure 40. United States Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Gout Therapeutics Sales Market Share by Type (2016-2026)

Figure 44. Europe Gout Therapeutics Sales Market Share by Application (2016-2026)

Figure 45. Europe Gout Therapeutics Revenue Market Share by Country (2016-2026)

Figure 46. Germany Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Gout Therapeutics Sales Market Share by Type (2016-2026)

Figure 52. Asia-Pacific Gout Therapeutics Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Gout Therapeutics Revenue Market Share by Region (2016-2026)

Figure 54. China Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Japan Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. South Korea Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. India Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Southeast Asia Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Australia Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South America Gout Therapeutics Sales Market Share by Type (2016-2026)

Figure 61. South America Gout Therapeutics Sales Market Share by Application (2016-2026)

Figure 62. South America Gout Therapeutics Revenue Market Share by Country (2016-2026)

Figure 63. Brazil Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Argentina Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Middle East and Africa Gout Therapeutics Sales Market Share by Type (2016-2026)

Figure 66. Middle East and Africa Gout Therapeutics Sales Market Share by Application (2016-2026)

Figure 67. Middle East and Africa Gout Therapeutics Revenue Market Share by Country (2016-2026)

Figure 68. Turkey Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Saudi Arabia Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. UAE Gout Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz